Inventor · disambiguated record
Mina J. Bissell
Also filed as: BISSELL MINA · BISSELL MINA J
15 granted patents·11 pending applications·138 citations·filing 1992–2015
91Inventor score
Top patents by PatentIndex Score
26 records- 0183US7618627B2Method of increasing radiation sensitivity by inhibition of beta one integrinUNIV CALIFORNIA·Filed 2005·Granted Nov 17, 2009·4 cites·16 claims
- 0282US6123941AMethod for restoration of normal phenotype in cancer cellsUNIV CALIFORNIA·Filed 1998·Granted Sep 26, 2000·43 cites·9 claims
- 0380US5846536ARestoration of normal phenotype in cancer cellsUNIV CALIFORNIA·Filed 1996·Granted Dec 8, 1998·36 cites·8 claims
- 0477US8715653B2Modulation of Rhamm (CD168) for selective adipose tissue developmentTURLEY EVA A·Filed 2007·Granted May 6, 2014·6 cites·19 claims
- 0577US8246952B2Method of increasing radiation sensitivity by inhibition of beta one integrinPARK CATHERINE·Filed 2009·Granted Aug 21, 2012·3 cites·13 claims
- 0670US10494402B2Peptides that stimulate subcutaneous adipogenesisUNIV CALIFORNIA·Filed 2013·Granted Dec 3, 2019·2 cites·15 claims
- 0768US6287790B1Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disordersUNIV CALIFORNIA·Filed 1999·Granted Sep 11, 2001·36 cites·4 claims
- 0860US2010062000A1Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell PopulationsUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 0959US10766927B2Peptides that stimulate subcutaneous adipogenesisUNIV CALIFORNIA·Filed 2013·Granted Sep 8, 2020·0 cites·26 claims
- 1059US7666850B2Drug screens based on the newly found role of dystroglycan proteolysis and restoration of dystroglycan function thereofUNIV CALIFORNIA·Filed 2005·Granted Feb 23, 2010·1 cites·5 claims
- 1155US9303088B2Detecting and treating breast cancer resistance to EGFR inhibitorsMOONLEE SUN-YOUNG·Filed 2011·Granted Apr 5, 2016·1 cites·8 claims
- 1247US2016130352A1Rhamm, a co-receptor and its interactions with other receptors in cancer cell motility and the identification of cancer prognitor cell populationsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 1345US2013052157A1Use of il-17e for cancer treatmentFURUTA SAORI·Filed 2009·Application pending·0 cites
- 1444US9689042B2Use of glycolytic pathways for inhibiting or measuring oncogenic signalingUNIV CALIFORNIA·Filed 2013·Granted Jun 27, 2017·0 cites·15 claims
- 1544US6753154B1Human AZU-1 gene, variants thereof and expressed gene productsUNIV CALIFORNIA·Filed 1999·Granted Jun 22, 2004·4 cites·13 claims
- 1644US2013157285A1Identification of invasive and slow-growing tumorigenic cell subsets in tumorsUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 1744US2009274626A1TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPYUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 1842US2012329663A114-3-3 sigma as a Biomarker of Basal CancerBOUDREAU AARON T·Filed 2011·Application pending·0 cites
- 1940US2015079071A1Non-catalytic domain targets in matrix metalloprotease proteins for cancer therapiesBISSELL MINA J·Filed 2013·Application pending·0 cites
- 2039US6982151B1Design of novel assays based on the newly found role of dystroglycan and alpha-dystroglycan proteolysis in tumor cell growthUNIV CALIFORNIA·Filed 2000·Granted Jan 3, 2006·0 cites·13 claims
- 2138US2017114329A1Scalable organotypic models of tumor dormancyGHAJAR CYRUS M·Filed 2015·Application pending·0 cites
- 2238US2013203069A1Dynamic Assay for Maintenance and Disruption of Tissue Level Organization and ArchitectureUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 2337US10844102B2Peptides, compositions, and methods for stimulating subcutaneous adipogenesisUNIV CALIFORNIA·Filed 2015·Granted Nov 24, 2020·0 cites·22 claims
- 2437US2009191543A1Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancyTHEREGENTS OF THE UNIVERSITY O·Filed 2006·Application pending·0 cites
- 2536US2013259807A1Cell culture screen for agents that control adipogenesis and myofibroblast differentiationBISSELL MINA J·Filed 2011·Application pending·0 cites
- 2629US6004805ATranscriptional enhancer from milk protein genesSEARLE & CO·Filed 1992·Granted Dec 21, 1999·2 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →